Allergic Fungal Rhinosinusitis
📧 Sign up to get email alerts when something new happens for Allergic Fungal Rhinosinusitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI) [Phase 3]
Phase 3 trial results for dupilumab in allergic fungal rhinosinusitis have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Add-on Dupilumab for AFRS as Postoperative Therapy (ADAPT) [Phase 3]
Phase 3 trial ADAPT evaluating add-on dupilumab for allergic fungal rhinosinusitis after surgery was terminated, with results posted in May …
-
CLINICAL_TRIALS withdrawal · 2024-07-25Clinical Trial Update: Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray [Phase 3]
A Phase 3 trial evaluating dupilumab for Allergic Fungal Rhinosinusitis after endoscopic sinus surgery has been withdrawn.